CareDx (CDNA) Research & Development (2013 - 2026)

CareDx has disclosed Research & Development across 14 years of filings, most recently posting $21.4 million for Q1 2026.

• Research & Development for Q1 2026 came in at $21.4 million, up 15.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $74.3 million (up 2.76% YoY), and the FY2025 annual result was $71.4 million, down 1.49% from the prior year.
• Research & Development came in at $21.4 million for Q1 2026 at CareDx, up from $19.3 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $24.4 million in Q1 2023 to a low of $16.6 million in Q4 2024.
• The 5-year median for Research & Development is $19.3 million (2025), against an average of $19.9 million.
• Across the five-year window, Research & Development soared 36.72% in 2022 and declined 23.18% in 2024, its largest moves.
• CareDx's Research & Development stood at $23.6 million in 2022, then fell by 20.11% to $18.8 million in 2023, then slipped by 11.74% to $16.6 million in 2024, then advanced by 16.16% to $19.3 million in 2025, then gained by 10.93% to $21.4 million in 2026.
• The last three Research & Development figures came in at $21.4 million (Q1 2026), $19.3 million (Q4 2025), and $16.8 million (Q3 2025), per Business Quant data.